title: Impact of the immune system and immunotherapy in colorectal cancer.
abstract: The development of cancer is a multi-step process involving the gradual loss of regulation over the growth and functional capabilities of normal cells. Much research has been focused on the numerous cell intrinsic factors that govern this process; however, recent attention has turned to understanding the cell extrinsic factors in the tumor microenvironment that appear equally critical to the progression and treatment of cancer. One critical component of the tumor microenvironment is the immune system and it has become increasingly evident that the immune system plays an integral role in preventing and promoting the development of cancer. Understanding the immune cell types and pathways involved in this process has enabled the development of novel biomarkers for prognosis and accelerated the development of immune-based therapeutics, both of which have the potential to forever change the treatment paradigms for colorectal cancer (CRC). In this review, we discuss the impact of the immune system on the initiation, progression and treatment of cancer, specifically focusing on CRC.
authors.affiliation: 1 Department of Biomedical Sciences, 2 Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Janet L
authors.initials: JL
authors.lastname: Markman
authors.affiliation: 1 Department of Biomedical Sciences, 2 Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Shiao
keywords: Immune system; colorectal cancer (CRC); immunotherapy; inflammation
references.citation: J Clin Oncol. 2008 Sep 20;26(27):4410-7
references.pmid: 18802153
references.citation: N Engl J Med. 2013 Jul 11;369(2):122-33
references.pmid: 23724867
references.citation: Cancer Res. 2005 May 15;65(10):3998-4004
references.pmid: 15899788
references.citation: PLoS One. 2013 Jul 24;8(7):e70417
references.pmid: 23894654
references.citation: Semin Immunopathol. 2013 Mar;35(2):229-44
references.pmid: 23161445
references.citation: Ann Oncol. 2006 Jun;17(6):974-80
references.pmid: 16600979
references.citation: Nat Immunol. 2002 Nov;3(11):991-8
references.pmid: 12407406
references.citation: PLoS One. 2013;8(2):e57114
references.pmid: 23437326
references.citation: Clin Cancer Res. 2014 May 1;20(9):2457-65
references.pmid: 24634374
references.citation: Oncogene. 2010 Feb 25;29(8):1093-102
references.pmid: 19946335
references.citation: J Leukoc Biol. 2008 Oct;84(4):988-93
references.pmid: 18515327
references.citation: Cancer Prev Res (Phila). 2013 Jan;6(1):18-26
references.pmid: 23248097
references.citation: Clin Cancer Res. 2011 Feb 15;17(4):678-89
references.pmid: 21325295
references.citation: Cancer Immunol Immunother. 2011 Oct;60(10):1473-84
references.pmid: 21660450
references.citation: Immunotherapy. 2010 May;2(3):305-27
references.pmid: 20635898
references.citation: Cancer Immunol Immunother. 2014 Mar;63(3):225-34
references.pmid: 24327292
references.citation: J Clin Invest. 2008 Jul;118(7):2516-25
references.pmid: 18521188
references.citation: Cancer Immunol Immunother. 2013 Jan;62(1):125-35
references.pmid: 22847020
references.citation: Immunity. 2013 Jul 25;39(1):38-48
references.pmid: 23890062
references.citation: J Clin Oncol. 1996 Dec;14(12):3133-40
references.pmid: 8955659
references.citation: Mol Ther. 2011 Mar;19(3):620-6
references.pmid: 21157437
references.citation: N Engl J Med. 2012 Jun 28;366(26):2443-54
references.pmid: 22658127
references.citation: Cell. 2010 Mar 19;140(6):883-99
references.pmid: 20303878
references.citation: J Clin Oncol. 2000 Jan;18(1):148-57
references.pmid: 10623705
references.citation: Int J Cancer. 2013 Apr 1;132(7):1581-91
references.pmid: 22948952
references.citation: Nat Rev Cancer. 2006 Jan;6(1):24-37
references.pmid: 16397525
references.citation: J Clin Oncol. 2004 Feb 1;22(3):403-15
references.pmid: 14691123
references.citation: Nature. 2011 Jun 08;475(7355):222-5
references.pmid: 21654748
references.citation: Ann Surg. 2006 Dec;244(6):986-92; discussion 992-3
references.pmid: 17122624
references.citation: BMC Gastroenterol. 2009 Sep 04;9:65
references.pmid: 19732435
references.citation: Oncoimmunology. 2014 Jan 1;3(1):e27048
references.pmid: 24605265
references.citation: Lancet Oncol. 2009 Sep;10(9):877-84
references.pmid: 19656725
references.citation: Clin Cancer Res. 2011 Jun 15;17(12):3884-91
references.pmid: 21680544
references.citation: Mol Ther. 2010 Apr;18(4):843-51
references.pmid: 20179677
references.citation: Clin Cancer Res. 2011 Jul 1;17(13):4550-7
references.pmid: 21498393
references.citation: Clin Cancer Res. 2013 Jul 1;19(13):3640-8
references.pmid: 23685836
references.citation: Int J Cancer. 2009 Aug 15;125(4):868-78
references.pmid: 19408303
references.citation: J Natl Cancer Inst. 1981 Mar;66(3):483-8
references.pmid: 6937705
references.citation: Clin Cancer Res. 2009 Feb 1;15(3):1086-95
references.pmid: 19188184
references.citation: Immunol Rev. 2011 Jan;239(1):27-44
references.pmid: 21198663
references.citation: J Immunother. 2001 Mar-Apr;24(2):130-7
references.pmid: 11265770
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: J Transl Med. 2012 Jan 03;10:1
references.pmid: 22214470
references.citation: Nat Rev Immunol. 2012 Mar 22;12(4):269-81
references.pmid: 22437939
references.citation: N Engl J Med. 2013 Apr 18;368(16):1509-18
references.pmid: 23527958
references.citation: J Exp Med. 2000 Feb 21;191(4):661-8
references.pmid: 10684858
references.citation: Am J Pathol. 2003 Feb;162(2):691-702
references.pmid: 12547727
references.citation: Nat Rev Immunol. 2009 Mar;9(3):162-74
references.pmid: 19197294
references.citation: J Clin Oncol. 2010 Jul 20;28(21):3485-90
references.pmid: 20498386
references.citation: J Clin Oncol. 2011 Mar 1;29(7):917-24
references.pmid: 21282551
references.citation: Clin Cancer Res. 2005 Feb 15;11(4):1474-82
references.pmid: 15746049
references.citation: Nat Rev Cancer. 2012 Mar 22;12(4):252-64
references.pmid: 22437870
references.citation: N Engl J Med. 2011 Aug 25;365(8):725-33
references.pmid: 21830940
references.citation: Ann Surg. 2013 Dec;258(6):879-86
references.pmid: 23657083
references.citation: Clin Cancer Res. 2008 Aug 1;14 (15):4843-9
references.pmid: 18676757
references.citation: N Engl J Med. 2010 Aug 19;363(8):711-23
references.pmid: 20525992
references.citation: Anticancer Res. 2009 Jul;29(7):2727-37
references.pmid: 19596953
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61
references.pmid: 9636188
references.citation: J Exp Med. 1990 Jul 1;172(1):231-7
references.pmid: 2193096
references.citation: Cancer Cell. 2004 May;5(5):443-53
references.pmid: 15144952
references.citation: Adv Cancer Res. 2003;90:127-56
references.pmid: 14710949
references.citation: Blood. 2002 May 1;99(9):3302-9
references.pmid: 11964297
references.citation: Nat Immunol. 2013 Oct;14(10):1014-22
references.pmid: 24048123
references.citation: Proc Natl Acad Sci U S A. 1982 Aug;79(15):4718-22
references.pmid: 6981814
references.citation: Oncoimmunology. 2012 Jul 1;1(4):407-408
references.pmid: 22754758
references.citation: Cancer Immunol Immunother. 2000 Nov;49(9):504-14
references.pmid: 11092617
references.citation: Front Immunol. 2013 Dec 10;4:436
references.pmid: 24339825
references.citation: World J Gastroenterol. 2012 Oct 28;18(40):5688-94
references.pmid: 23155308
references.citation: Lancet. 2007 Jul 7;370(9581):59-67
references.pmid: 17617273
references.citation: Nat Rev Cancer. 2008 Aug;8(8):618-31
references.pmid: 18633355
references.citation: Clin Cancer Res. 2000 Jun;6(6):2219-28
references.pmid: 10873071
references.citation: Cancer Immunol Immunother. 2009 Jan;58(1):61-9
references.pmid: 18488223
references.citation: J Clin Oncol. 2005 Feb 1;23(4):720-31
references.pmid: 15613691
references.citation: Cancer J. 2010 Jul-Aug;16(4):399-403
references.pmid: 20693853
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):317-9
references.pmid: 23250932
references.citation: Genes Dev. 2011 Dec 15;25(24):2559-72
references.pmid: 22190457
references.citation: Expert Opin Biol Ther. 2013 Jun;13(6):889-900
references.pmid: 23441760
references.citation: Immunity. 1994 Sep;1(6):447-56
references.pmid: 7895156
references.citation: Lancet. 2001 Feb 17;357(9255):539-45
references.pmid: 11229684
references.citation: Science. 2002 Oct 25;298(5594):850-4
references.pmid: 12242449
references.citation: Cancer Res. 2012 Jul 1;72(13):3153-62
references.pmid: 22564522
references.citation: Cell. 2012 Mar 16;148(6):1081-4
references.pmid: 22424219
references.citation: Clin Cancer Res. 2002 Jul;8(7):2044-51
references.pmid: 12114402
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):425-30
references.pmid: 19147746
references.citation: Cancer Sci. 2013 Jan;104(1):15-21
references.pmid: 23107418
references.citation: Chem Biol. 1996 Nov;3(11):895-904
references.pmid: 8939708
references.citation: Oncoimmunology. 2013 Dec 1;2(12):e26662
references.pmid: 24498551
references.citation: Nat Rev Drug Discov. 2012 Feb 03;11(3):215-33
references.pmid: 22301798
references.citation: J Clin Oncol. 2003 Feb 15;21(4):624-30
references.pmid: 12586798
references.citation: Annu Rev Immunol. 2004;22:329-60
references.pmid: 15032581
references.citation: Clin Cancer Res. 2014 Oct 1;20(19):5064-74
references.pmid: 24714771
references.citation: Cell. 2000 Oct 27;103(3):481-90
references.pmid: 11081634
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15840-2
references.pmid: 12461164
references.citation: BMC Cancer. 2014 Jan 29;14:48
references.pmid: 24475975
references.citation: Expert Opin Biol Ther. 2011 Nov;11(11):1409-18
references.pmid: 21871012
references.citation: Nat Rev Drug Discov. 2011 Feb;10 (2):101-11
references.pmid: 21283105
references.citation: J Natl Cancer Inst. 2013 Feb 20;105(4):256-65
references.pmid: 23291374
references.citation: Immunity. 2013 Jul 25;39(1):49-60
references.pmid: 23890063
references.citation: Nature. 2001 Apr 26;410(6832):1107-11
references.pmid: 11323675
references.citation: J Clin Oncol. 2003 Sep 1;21(17):3343-50
references.pmid: 12947071
references.citation: N Engl J Med. 2010 Jul 29;363(5):411-22
references.pmid: 20818862
references.citation: J Immunol. 2011 Apr 1;186(7):4388-95
references.pmid: 21357259
references.citation: Lancet. 2004 Feb 21;363(9409):594-9
references.pmid: 14987883
references.citation: Cell. 2010 Apr 2;141(1):39-51
references.pmid: 20371344
references.citation: N Engl J Med. 2012 Mar 8;366(10 ):925-31
references.pmid: 22397654
references.citation: J Immunol. 2007 Apr 1;178(7):4011-6
references.pmid: 17371953
references.citation: Immunol Res. 2013 Mar;55(1-3):34-47
references.pmid: 22936035
references.citation: Cell Host Microbe. 2014 Mar 12;15(3):295-305
references.pmid: 24629336
references.citation: Nature. 2014 Mar 6;507(7490):109-13
references.pmid: 24572365
references.citation: J Cell Mol Med. 2013 Sep;17(9):1088-95
references.pmid: 24151976
references.citation: Cancer Res. 2009 Mar 15;69(6):2685-93
references.pmid: 19258510
references.citation: Nat Rev Cancer. 2012 Mar 01;12 (4):307-13
references.pmid: 22378190
references.citation: Clin Cancer Res. 2012 Jun 1;18(11):3022-9
references.pmid: 22510350
references.citation: N Engl J Med. 2012 Jun 28;366(26):2455-65
references.pmid: 22658128
references.citation: Cancer J. 2011 Sep-Oct;17(5):359-71
references.pmid: 21952287
references.citation: Cancer Cell. 2012 Mar 20;21(3):309-22
references.pmid: 22439926
references.citation: Lancet. 2003 Jul 26;362(9380):305-15
references.pmid: 12892963
references.citation: Clin Cancer Res. 2001 Dec;7(12):3950-62
references.pmid: 11751487
references.citation: Nat Med. 1998 Mar;4(3):328-32
references.pmid: 9500607
references.citation: Nat Med. 1997 May;3(5):558-61
references.pmid: 9142127